Cognitive Decline Market Size, Share, and Growth Forecast 2026 - 2033

Cognitive Decline Market by Treatment (Drug therapy, Non-pharmacological therapy, Combination therapy), by Disease Type (Alzheimer's disease, Mild cognitive impairment (MCI), Vascular dementia, Parkinson's disease dementia, Lewy body dementia, Frontotemporal dementia, Others), by End User (Hospitals, Specialty clinics, Diagnostic centers, Research institutes), by Regional Analysis, 2026-2033

ID: PMRREP32968
Calendar

February 2026

198 Pages

Author : Abhijeet Surwase

  1. Executive Summary
    1. Global Cognitive Decline Market Snapshot 2026 and 2033
    2. Market Opportunity Assessment, 2026-2033, US$ Bn
    3. Key Market Trends
    4. Industry Developments and Key Market Events
    5. Demand Side and Supply Side Analysis
    6. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definitions
    2. Market Dynamics
      1. Driver
      2. Restraint
      3. Opportunities
      4. Trends
    3. Macro-Economic Factors
      1. Global GDP Outlook
      2. Global Healthcare Expenditure
    4. Forecast Factors – Relevance and Impact
    5. COVID-19 Impact Assessment
  3. Value Added Insights
    1. Value Chain analysis
    2. Key Market Players
    3. Disease Epidemiology
    4. Product Adoption Analysis
    5. Key Promotional Strategies by key players
    6. PESTLE Analysis
    7. Porter's Five Forces Analysis
    8. Regulatory and Technology Landscape
  4. Global Cognitive Decline Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Global Cognitive Decline Market Outlook: Treatment
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Treatment, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Treatment, 2026-2033
        1. Drug therapy
        2. Non-pharmacological therapy
        3. Combination therapy
      4. Market Attractiveness Analysis: Treatment
    3. Global Cognitive Decline Market Outlook: Disease Type
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Disease Type, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Disease Type, 2026-2033
        1. Alzheimer’s disease
        2. Mild cognitive impairment (MCI)
        3. Vascular dementia
        4. Parkinson’s disease dementia
        5. Lewy body dementia
        6. Frontotemporal dementia
        7. Others
      4. Market Attractiveness Analysis: Disease Type
    4. Global Cognitive Decline Market Outlook: End User
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by End User, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by End User, 2026-2033
        1. Hospitals
        2. Specialty clinics
        3. Diagnostic centers
        4. Research institutes
      4. Market Attractiveness Analysis: End User
  5. Global Cognitive Decline Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
    3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Cognitive Decline Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
    3. North America Market Size (US$ Bn) Forecast, by Treatment, 2026-2033
      1. Drug therapy
      2. Non-pharmacological therapy
      3. Combination therapy
    4. North America Market Size (US$ Bn) Forecast, by Disease Type, 2026-2033
      1. Alzheimer’s disease
      2. Mild cognitive impairment (MCI)
      3. Vascular dementia
      4. Parkinson’s disease dementia
      5. Lewy body dementia
      6. Frontotemporal dementia
      7. Others
    5. North America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty clinics
      3. Diagnostic centers
      4. Research institutes
  7. Europe Cognitive Decline Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Europe Market Size (US$ Bn) Forecast, by Treatment, 2026-2033
      1. Drug therapy
      2. Non-pharmacological therapy
      3. Combination therapy
    4. Europe Market Size (US$ Bn) Forecast, by Disease Type, 2026-2033
      1. Alzheimer’s disease
      2. Mild cognitive impairment (MCI)
      3. Vascular dementia
      4. Parkinson’s disease dementia
      5. Lewy body dementia
      6. Frontotemporal dementia
      7. Others
    5. Europe Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty clinics
      3. Diagnostic centers
      4. Research institutes
  8. East Asia Cognitive Decline Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    3. East Asia Market Size (US$ Bn) Forecast, by Treatment, 2026-2033
      1. Drug therapy
      2. Non-pharmacological therapy
      3. Combination therapy
    4. East Asia Market Size (US$ Bn) Forecast, by Disease Type, 2026-2033
      1. Alzheimer’s disease
      2. Mild cognitive impairment (MCI)
      3. Vascular dementia
      4. Parkinson’s disease dementia
      5. Lewy body dementia
      6. Frontotemporal dementia
      7. Others
    5. East Asia Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty clinics
      3. Diagnostic centers
      4. Research institutes
  9. South Asia & Oceania Cognitive Decline Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of SAO
    3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Treatment, 2026-2033
      1. Drug therapy
      2. Non-pharmacological therapy
      3. Combination therapy
    4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Disease Type, 2026-2033
      1. Alzheimer’s disease
      2. Mild cognitive impairment (MCI)
      3. Vascular dementia
      4. Parkinson’s disease dementia
      5. Lewy body dementia
      6. Frontotemporal dementia
      7. Others
    5. South Asia & Oceania Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty clinics
      3. Diagnostic centers
      4. Research institutes
  10. Latin America Cognitive Decline Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of LATAM
    3. Latin America Market Size (US$ Bn) Forecast, by Treatment, 2026-2033
      1. Drug therapy
      2. Non-pharmacological therapy
      3. Combination therapy
    4. Latin America Market Size (US$ Bn) Forecast, by Disease Type, 2026-2033
      1. Alzheimer’s disease
      2. Mild cognitive impairment (MCI)
      3. Vascular dementia
      4. Parkinson’s disease dementia
      5. Lewy body dementia
      6. Frontotemporal dementia
      7. Others
    5. Latin America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty clinics
      3. Diagnostic centers
      4. Research institutes
  11. Middle East & Africa Cognitive Decline Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. GCC Countries
      2. South Africa
      3. Northern Africa
      4. Rest of MEA
    3. Middle East & Africa Market Size (US$ Bn) Forecast, by Treatment, 2026-2033
      1. Drug therapy
      2. Non-pharmacological therapy
      3. Combination therapy
    4. Middle East & Africa Market Size (US$ Bn) Forecast, by Disease Type, 2026-2033
      1. Alzheimer’s disease
      2. Mild cognitive impairment (MCI)
      3. Vascular dementia
      4. Parkinson’s disease dementia
      5. Lewy body dementia
      6. Frontotemporal dementia
      7. Others
    5. Middle East & Africa Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty clinics
      3. Diagnostic centers
      4. Research institutes
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
    3. Company Profiles
      1. Biogen Inc.
        1. Company Overview
        2. Product Portfolio/Offerings
        3. Key Financials
        4. SWOT Analysis
        5. Company Strategy and Key Developments
      2. Eisai Co., Ltd.
      3. Eli Lilly and Company
      4. F. Hoffmann-La Roche Ltd.
      5. Novartis AG
      6. Johnson & Johnson
      7. Pfizer Inc.
      8. Merck & Co., Inc.
      9. AbbVie Inc.
      10. H. Lundbeck A/S
      11. Takeda Pharmaceutical Company
      12. AstraZeneca plc
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -